DeoxymikanolideCAS# 23753-57-3 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 23753-57-3 | SDF | Download SDF |
PubChem ID | 14081913 | Appearance | Powder |
Formula | C15H16O5 | M.Wt | 276.28 |
Type of Compound | Sesquiterpenoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (1R,2R,6S,8S,10S)-8-methyl-3-methylidene-5,9,15-trioxatetracyclo[11.2.1.02,6.08,10]hexadec-13(16)-ene-4,14-dione | ||
SMILES | CC12CC3C(C4C=C(CCC1O2)C(=O)O4)C(=C)C(=O)O3 | ||
Standard InChIKey | XASRCIGCTSZFAS-SQRMYFJTSA-N | ||
Standard InChI | InChI=1S/C15H16O5/c1-7-12-9-5-8(14(17)18-9)3-4-11-15(2,20-11)6-10(12)19-13(7)16/h5,9-12H,1,3-4,6H2,2H3/t9-,10+,11+,12+,15+/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Deoxymikanolide Dilution Calculator
Deoxymikanolide Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.6195 mL | 18.0976 mL | 36.1952 mL | 72.3903 mL | 90.4879 mL |
5 mM | 0.7239 mL | 3.6195 mL | 7.239 mL | 14.4781 mL | 18.0976 mL |
10 mM | 0.362 mL | 1.8098 mL | 3.6195 mL | 7.239 mL | 9.0488 mL |
50 mM | 0.0724 mL | 0.362 mL | 0.7239 mL | 1.4478 mL | 1.8098 mL |
100 mM | 0.0362 mL | 0.181 mL | 0.362 mL | 0.7239 mL | 0.9049 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 4,5-Dihydropiperlonguminine
Catalog No.:BCN9419
CAS No.:23512-53-0
- Dihydromikanolide
Catalog No.:BCN9418
CAS No.:23758-04-5
- 2,6-Dihydroxyxanthone
Catalog No.:BCN9417
CAS No.:838-11-9
- Minisecolide C
Catalog No.:BCN9416
CAS No.:1967030-77-8
- Withaphysalin A
Catalog No.:BCN9415
CAS No.:57423-72-0
- Withaphysalin E
Catalog No.:BCN9414
CAS No.:118985-24-3
- Withaphysalin S
Catalog No.:BCN9413
CAS No.:949172-13-8
- Methyl (9Z,11E)-13-hydroxyoctadeca-9,11-dienoate
Catalog No.:BCN9412
CAS No.:109837-85-6
- Physaminimin C
Catalog No.:BCN9411
CAS No.:1582259-03-7
- Physaminimin D
Catalog No.:BCN9410
CAS No.:1582259-05-9
- Hyperxanthone
Catalog No.:BCN9409
CAS No.:99481-41-1
- 5-Carboxystrictosidine
Catalog No.:BCN9408
CAS No.:34371-47-6
- Macluraxanthone
Catalog No.:BCN9421
CAS No.:5848-14-6
- 4-Hydroxyxanthone
Catalog No.:BCN9422
CAS No.:14686-63-6
- 3-(Hydroxyacetyl)indole
Catalog No.:BCN9423
CAS No.:2400-51-3
- Minisecolide D
Catalog No.:BCN9424
CAS No.:1967030-78-9
- Lipodeoxyaconitine
Catalog No.:BCN9425
CAS No.:244190-83-8
- Lipoaconitine
Catalog No.:BCN9426
CAS No.:81941-14-2
- 3-epi-Dihydroscandenolide
Catalog No.:BCN9427
CAS No.:1137951-08-6
- cis-Shegansu B
Catalog No.:BCN9428
CAS No.:865474-99-3
- Methyl 2,4,6-trihydroxybenzoate
Catalog No.:BCN9429
CAS No.:3147-39-5
- Elatoside E
Catalog No.:BCN9430
CAS No.:156980-30-2
- 1H-Indole-3-carbaldehyde
Catalog No.:BCN9431
CAS No.:487-89-8
- Scandenolide
Catalog No.:BCN9432
CAS No.:23758-16-9
Asteraceae Plants as Sources of Compounds Against Leishmaniasis and Chagas Disease.[Pubmed:31156427]
Front Pharmacol. 2019 May 8;10:477.
Leishmaniasis and Chagas disease cause great impact on social and economic aspects of people living in developing countries. The treatments for these diseases are based on the same regimen for over 40 years, thus, there is an urgent need for the development of new drugs. In this scenario, Asteraceae plants (a family widely used in folk medicine worldwide) are emerging as an interesting source for new trypanocidal and leishmanicidal compounds. Herein, we provide a non-exhaustive review about the activity of plant-derived products from Asteraceae with inhibitory action toward Leishmania spp. and T. cruzi. Special attention was given to those studies aiming the isolation (or identification) of the bioactive compounds. Ferulic acid, rosmarinic acid, and ursolic acid (Baccharis uncinella DC.) were efficient to treat experimental leishmaniasis; while Deoxymikanolide (Mikania micrantha) and (+)-15-hydroxy-labd-7-en-17-al (Aristeguietia glutinosa Lam.) showed in vivo anti-T. cruzi action. It is also important to highlight that several plant-derived products (compounds, essential oils) from Artemisia plants have shown high inhibitory potential against Leishmania spp., such as artemisinin and its derivatives. In summary, these compounds may help the development of new effective agents against these neglected diseases.
Primary targets of the sesquiterpene lactone deoxymikanolide on Trypanosoma cruzi.[Pubmed:30668348]
Phytomedicine. 2019 Mar 15;56:27-34.
BACKGROUND: Deoxymikanolide is a sesquiterpene lactone isolated from Mikania micrantha and M. variifolia which, has previously demonstrated in vitro activity on Trypanosoma cruzi and in vivo activity on an infected mouse model. PURPOSE: Based on these promising findings, the aim of this study was to investigate the mechanism of action of this compound on different parasite targets. METHODS: The interaction of Deoxymikanolide with hemin was examined under reducing and non- reducing conditions by measuring modifications in the Soret absorption band of hemin; the thiol interaction was determined spectrophotometrically through its reaction with 5,5'-dithiobis-2-nitrobenzoate in the presence of glutathione; activity on the parasite antioxidant system was evaluated by measuring the activity of the superoxide dismutase and trypanothione reductase enzymes, together with the intracellular oxidative state by flow cytometry. Superoxide dismutase and trypanothione reductase activities were spectrophotometrically tested. Cell viability, phosphatidylserine exposure and mitochondrial membrane potential were assessed by means of propidium iodide, annexin-V and rhodamine 123 staining, respectively; sterols were qualitatively and quantitatively tested by TLC; ultrastructural changes were analyzed by transmission electron microscopy. Autophagic cells were detected by staining with monodansylcadaverine. RESULTS: Deoxymikanolide decreased the number of reduced thiol groups within the parasites, which led to their subsequent vulnerability to oxidative stress. Treatment of the parasites with the compound produced a depolarization of the mitochondrial membrane even though the plasma membrane permeabilization was not affected. Deoxymikanolide did not affect the intracellular redox state and so the mitochondrial dysfunction produced by this compound could not be attributed to ROS generation. The antioxidant defense system was affected by Deoxymikanolide at twenty four hours of treatment, when both an increased oxidative stress and decreased activity of superoxide dismutase and trypanothione reductase (40 and 60% respectively) were observed. Both the oxidative stress and mitochondrial dysfunction induce parasite death by apoptosis and autophagy. CONCLUSION: Based on our results, Deoxymikanolide would exert its anti-T cruzi activity as a strong thiol blocking agent and by producing mitochondrial dysfunction.
Assessment of sesquiterpene lactones isolated from Mikania plants species for their potential efficacy against Trypanosoma cruzi and Leishmania sp.[Pubmed:28945741]
PLoS Negl Trop Dis. 2017 Sep 25;11(9):e0005929.
Four sesquiterpene lactones, mikanolide, Deoxymikanolide, dihydromikanolide and scandenolide, were isolated by a bioassay-guided fractionation of Mikania variifolia and Mikania micrantha dichloromethane extracts. Mikanolide and Deoxymikanolide were the major compounds in both extracts (2.2% and 0.4% for Mikania variifolia and 21.0% and 6.4% for Mikania micrantha respectively, calculated on extract dry weight). Mikanolide, Deoxymikanolide and dihydromikanolide were active against Trypanosoma cruzi epimastigotes (50% inhibitory concentrations of 0.7, 0.08 and 2.5 mug/mL, for each compound respectively). These sesquiterpene lactones were also active against the bloodstream trypomastigotes (50% inhibitory concentrations for each compound were 2.1, 1.5 and 0.3 mug/mL, respectively) and against amastigotes (50% inhibitory concentrations for each compound were 4.5, 6.3 and 8.5 mug/mL, respectively). By contrast, scandenolide was not active on Trypanosoma cruzi. Besides, mikanolide and Deoxymikanolide were also active on Leishmania braziliensis promastigotes (50% inhibitory concentrations of 5.1 and 11.5 mug/mL, respectively). The four sesquiterpene lactones were tested for their cytotoxicity on THP 1 cells. Deoxymikanolide presented the highest selectivity index for trypomastigotes (SI = 54) and amastigotes (SI = 12.5). In an in vivo model of Trypanosoma cruzi infection, Deoxymikanolide was able to decrease the parasitemia and the weight loss associated to the acute phase of the parasite infection. More importantly, while 100% of control mice died by day 22 after receiving a lethal T. cruzi infection, 70% of Deoxymikanolide-treated mice survived. We also observed that this compound increased TNF-alpha and IL-12 production by macrophages, which could contribute to control T. cruzi infection.
Insecticidal Constituents from Buddlej aalbiflora Hemsl.[Pubmed:27764958]
Nat Prod Res. 2017 Jun;31(12):1446-1449.
Eleven known compounds, Deoxymikanolide (1), 1,3-dihydroxyxanthone (2), kumatakenin (3), apigenin (4), chrysin (5), kaempferol (6), Iso-kaempferol (7), luteolin (8), luteolin-3',4'-dimethylether-7-O-beta-glucoside (9), luteolin-7-O-beta-glucoside (10) and quercetin (11) were identified in MeOH extract of Buddleja albiflora Hemsl (Oleaceae). These compounds (each, 1, 0.5 and 0.25 mg mL(-1)) were tested for insecticidal activity against 3rd and 4th-instar larvae of Plutella xylostella, 3rd-instar larvae of Mythimna separata and 3rd-instar larvae of Macrosiphoniella sanborni. The lowest 50% anti-feedant concentration (AFC50) against P. xylostella and 50% lethal concentration (LC50) against P. xylostella and M. sanborni were observed as 0.0058, 0.0046 and 3.4048 mg L(-1), respectively.
Antimicrobial constituents of the leaves of Mikania micrantha H. B. K.[Pubmed:24098556]
PLoS One. 2013 Oct 2;8(10):e76725.
BACKGROUND: To isolate plant-derived compounds with antimicrobial activity from the leaves of Mikania micrantha, to determine the compounds configuration, and to evaluate their antimicrobial activity against eight plant pathogenic fungi (Exserohilum turcicum, Colletotrichum lagenarium, Pseudoperonispora cubensis, Botrytis cirerea, Rhizoctonia solani, Phytophthora parasitica, Fusarium solani, and Pythium aphanidermatum,) and four plant pathogenic bacteria (gram negative bacteria: Ralstonia dolaanacearum, Xanthomonas oryzae pv. Oryzae, Xanthomonas Campestris pv. Vesicatoria, and Xanthomonas campestris pv. Citri), and four bacteria (gram positive bacteria: Staphyloccocus aureus, Bacillus subtilis, Micrococcus luteus, and Bacillus cereus). METHODS AND RESULTS: Antimicrobial constituents of the leaves of M. micrantha were isolated using bioactivity- guided fractionation. The antifungal activity of the isolated compounds was evaluated by the inhibit hypha growth method and inhibit spore germination method. Characterization of antibacterial activity was carried out using the minimum inhibitory concentrations (MICs) and the minimum bactericidal concentrations (MBCs). MIC and MBC were determined by the broth microdilution method. Six compounds - Deoxymikanolide, scandenolide, dihydroscandenolide, mikanolide, dihydromikanolide, and m - methoxy benzoic acid - have been isolated from leaves of Mikania micrantha H. B. K. Deoxymikanolide, scandenolide, and dihydroscandenolide were new compounds. The result of bioassay showed that all of isolated compounds were effective against tested strains and Deoxymikanolide showed the strongest activity. CONCLUSIONS AND SIGNIFICANCE: The leaves of M. micrantha may be a promising source in the search for new antimicrobial drugs due to its efficacy and the broadest range. Meanwhile, adverse impact of M. micrantha will be eliminated.
Potential allelochemicals from an invasive weed Mikania micrantha H.B.K.[Pubmed:16222800]
J Chem Ecol. 2005 Jul;31(7):1657-68.
Phytotoxicity-directed extraction and fractionation of the aerial parts of Mikania micrantha H.B.K. led to the isolation and identification of three sesquiterpenoids: dihydromikanolide, Deoxymikanolide, and 2,3-epoxy-1-hydroxy-4,9-germacradiene-12,8:15,6-diolide. These sesquiterpenoids inhibited both germination and seedling growth of tested species with Deoxymikanolide possessing the strongest phytotoxicity. In a bioassay against lettuce (Lectuca sativa L.), Deoxymikanolide reduced radicle elongation at low concentration (IC50 = 47 microg/ml); dihydromikanolide showed a weaker effect (IC50 = 96 microg/ml), and 2,3-epoxy-1-hydroxy-4,9-germacradiene-12,8:15,6-diolide exhibited the least effect (IC50 = 242 microg/ml). Deoxymikanolide caused yellowish lesions at the root tips of lettuce at a concentration of 50 microg/ml, and a 250 microg/ml solution killed lettuce seedlings. A bioassay against the monocot ryegrass (Lolium multiforum) revealed similar results on radicle elongation, which implied that the growth inhibition by these compounds was not selective. To evaluate their phytotoxicity to plants in natural habitats, three common companion tree species in south China, Acacia mangium, Eucalyptus robusta, and Pinus massoniana, were also tested and similar results were obtained. This is the first report on the isolation of 2,3-epoxy-1-hydroxy-4,9-germacradiene-12,8:15,6-diolide as a naturally occurring product.
Analgesic sesquiterpene dilactone from Mikania cordata.[Pubmed:11731117]
Fitoterapia. 2001 Dec;72(8):919-21.
The crude extract of Mikania cordata (1 and 3 g/kg, p.o.) and Deoxymikanolide (1) (10 mg/kg, p.o.) significantly inhibited acetic acid-induced writhing in mice. Three other sesquiterpene dilactones isolated from the same plant, namely mikanolide, dihydromikanolide and scandenolide, did not show significant analgesic activity.
Germacra-1,10Z,4E-dien-12,8alpha-olides from Mikania micrantha.[Pubmed:17268979]
Planta Med. 1987 Feb;53(1):105-6.
The aerial parts of MIKANIA MICRANTHA from a collection in Paraguay gave, in addition to mikanolide, Deoxymikanolide, and miscandenin, five new germacranolides all derived from 14,15-dihydroxygermacra-1(10) E,4 Z-dien-12,8alpha-olide.